抗腫瘍免疫を強化する共性植物産物
Misao Takemoto1, Sara Delghandi2, Masahiro Abo1
1Division of Biochemistry, Institute for Chemical Research (ICR), Kyoto University, Uji, Kyoto 611-0011, Japan.
Journal of the American Chemical Society
|January 10, 2025
まとめ
自然成分であるArvenin Iは,MKK3を標的にして,枯渇したT細胞を活性化させ,がん免疫療法の有効性を高めます. この共性キナーゼ活性化剤は 抗腫瘍免疫の強化に 有望であることが示されています
科学分野:
- 免疫学
- 薬理学について
- 自然製品 化学
背景:
- 免疫チェックポイント阻害剤は有望な治療効果を示していますが,腫瘍の微小環境におけるT細胞機能障害によって制限されています.
- 小分子併用療法には 臨床的な課題があります
- 抗腫瘍免疫を活性化する 新しい戦略の開発は 癌の治療に不可欠です
研究 の 目的:
- 抗腫瘍免疫の新規活性化剤を特定する
- 癌の微小環境でT細胞の枯渇を克服できる化合物をスクリーニングする細胞ベースのシステムを開発する.
主な方法:
- 細胞ベースのスクリーニング 232 電気的機能群を持つ天然製品.
- 分子標的と経路を決定するための化学タンパク質と機械学的分析.
- 免疫療法と併用した治療の可能性を評価するためにマウスでのin vivo研究.
主要な成果:
- アルヴェニンI (キュキュルビタシンB2Oβ- d- グルコシド) はT細胞活性化剤として特定されました.
- アルヴェニンIはMK3を共性的に活性化し,p38MAPK経路の活性化につながり,枯渇したT細胞のミトコンドリアフィットネスを改善します.
- アルヴェニンIは,マウスのがんに対する免疫療法の有効性を,単独療法と免疫チェックポイント阻害剤との組み合わせの両方で高めました.
結論:
- アルヴェニンIは T細胞を活性化する強力な共性キナーゼ活性化剤です.
- アルヴェニンIは,がんの免疫療法を強化し,抗腫瘍免疫を強化する大きな可能性を示しています.
さらに関連する動画
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.1K
09:01Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
280
関連する概念動画
01:27Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
01:27Cytotoxic T Cells-mediated Immune Response
841
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
841
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:30Cancer Vaccines
337
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
337
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
01:45Positive Regulator Molecules
105.7K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
105.7K